Primary mediastinal large B-cell lymphomas treated with dose-intensified CHOP alone or CHOP combined with radiotherapy

Leukemia and Lymphoma

Volumn 49, Issue 8, 2008, Pages 1510-1515

  Massoud, Marcel ^a   Koscielny, Serge ^a   Lapusan, Simona ^a   Bosq, Jacques ^a   Ribrag, Vincent ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

ACVBP chemotherapy; Mediastinal lymphoma; Prognostic factors; Radiotherapy

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE; VINDESINE;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM CANCER; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MEDIASTINAL NEOPLASMS; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 51349110960     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802203788     Document Type: Article

References (26)

1. Jaffe, E. S., Harris, N. L., Stein, H. and Vardiman, J. (2001) World Health Organisation Classification of Tumours, Vol 3: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues, IARC Press, Lyon, France
2. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. Cleary, M. L. et al. (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood, 84, pp. 1361-1392.
3. Barth, T. F., Leithauser, F., Joos, S., Bentz, M. and Moller, P. (2002) Mediastinal (thymic) large B-cell lymphoma: Where do we stand?. Lancet Oncol, 3, pp. 229-234.
4. Lazzarino, M., Orlandi, E., Paulli, M., Strater, J., Klersy, C. Gianelli, U. et al. (1997) Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicenter study of 106 patients. J Clin Oncol, 15, pp. 1646-1653.
5. Lazzarino, M., Orlandi, E., Paulli, M., Boveri, E., Morra, E. Brusamolino, E. et al. (1993) Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol, 11, pp. 2306-2313.
6. Kirn, D., Mauch, P., Shaffer, K., Pinkus, G., Shipp, M. A. Kaplan, W. D. et al. (1993) Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol, 11, pp. 1336-1343.
7. Savage, K. J., Monti, S., Kutok, J. L., Cattoretti, G., Neuberg, D. De Leval, L. et al. (2003) The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood, 102, pp. 3871-3879.
8. Rosenwald, A., Wright, G., Leroy, K., Yu, X., Gaulard, P. Gascoyne, R. D. et al. (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med, 198, pp. 851-862.
9. Copie-Bergman, C., Plonquet, A., Alonso, M. A., Boulland, M. L., Marquet, J. Divine, M. et al. (2002) MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol, 15, pp. 1172-1180.
10. Bentz, M., Barth, T. F., Bruderlein, S., Bock, D., Schwerer, M. J. Baudis, M. et al. (2001) Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer, 30, pp. 393-401.
11. Joos, S., Otano-Joos, M. I., Ziegler, S., Bruderlein, S., du Manoir, S Bentz, M. et al. (1996) Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood, 87, pp. 1571-1578.
12. Melzner, I., Bucur, A. J., Bruderlein, S., Dorsch, K., Hasel, C. Barth, T. F. et al. (2005) Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood, 105, pp. 2535-2542.
13. Hamlin, P. A., Portlock, C. S., Straus, D. J., Noy, A., Singer, A. Horwitz, S. M. et al. (2005) Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999. Br J Haematol, 130, pp. 691-699.
14. Todeschini, G., Secchi, S., Morra, E., Vitolo, U., Orlandi, E. Pasini, F. et al. (2004) Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer, 90, pp. 372-376.
15. Cairoli, R., Grillo, G., Tedeschi, A., Gargantini, L., Marenco, P. Tresoldi, E. et al. (2002) Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Bone Marrow Transplant, 29, pp. 473-477.
16. Savage, K. J., Al-Rajhi, N., Voss, N., Paltiel, C., Klasa, R. Gascoyne, R. D. et al. (2006) Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: The British Columbia experience. Ann Oncol, 17, pp. 123-130.
17. Cazals-Hatem, D., Lepage, E., Brice, P., Ferrant, A., d'Agay, M. F. Baumelou, E. et al. (1996) Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol, 20, pp. 877-888.
18. van Besien, K., Kelta, M. and Bahaguna, P. (2001) Primary mediastinal B-cell lymphoma: A review of pathology and management. J Clin Oncol, 19, pp. 1855-1864.
19. Zinzani, P. L., Martelli, M., Bertini, M., Gianni, A. M., Devizzi, L. Federico, M. et al. (2002) International Extranodal Lymphoma Study Group (IELSG). Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: A retrospective multinational study on 426 previously untreated patients. Haematologica, 87, pp. 1258-1264.
20. Reyes, F., Lepage, E., Ganem, G., Molina, T. J., Brice, P. Coiffier, B. et al. (2005) Groupe d'Etude des Lymphomes de l'Adulte (GELA). ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med, 352, pp. 1197-1205.
21. Shipp, M., Harrington, D., Anderson, J. R., Armitage, J. O., Bonadonna, G. Brittinger, G. et al. (1993) The International non-Hodgkin's Lymphoma Prognostic Factor Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med, 329, pp. 987-994.
22. Tilly, H., Mounier, N., Lederlin, P., Briere, J., Dupriez, B. Sebban, C. et al. (2000) Randomized comparison of ACVBP ad m-BACOD in the treatment of patients with low-risk aggressive lymphoma: The LNH 87-1 study. J ClinOncol, 18, pp. 1309-1315.
23. Tilly, H., Lepage, E., Coiffier, B., Blanc, M., Herbrecht, R. Bosly, A. et al. (2003) Groupe d'Etude des Lymphomes de l'Adulte. Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma. Blood, 102, pp. 4284-4289.
24. Haioun, C., Lepage, E., Gisselbrecht, C., Salles, G., Coiffier, B. Brice, P. et al. (2000) Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH-87 protocol. A Groupe d'Etude des Lymphomes de l'Adulte study. J Clin Oncol, 18, pp. 3025-3030.
25. Hill, D. A., Gilbert, E., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E. Holowaty, E. et al. (2005) Breast cancer risk following radiotherapy for Hodgkin lymphoma: Modification by other risk factors. Blood, 106, pp. 3358-3365.
26. Travis, L. B., Hill, D., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E. Holowaty, E. et al. (2005) Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst, 97, pp. 1428-1437.